BUSINESS● LOW3h ago · Sep 10, 2026, 3:49 PM
Revolution a new overweight at Morgan Stanley on RAS-targeted oncology franchise
Seeking Alpha Tech · global
Morgan Stanley has given a new 'overweight' rating to Revolution based on its RAS-targeted oncology franchise. This indicates a positive outlook from the financial firm on the company's performance in cancer treatment development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS24m agoWhy Nigeria Port charges must drop — UsmanVanguard NigeriaBUSINESS27m agoFreeport-McMoRan attractively valued after White House copper tariff uncertainty, Goldman saysSeeking Alpha TechBUSINESS28m agoInvestors price in hot August CPI reading; big surprise could sway upcoming FOMC decisionSeeking Alpha TechBUSINESS29m agoAP has the potential to be world class tourism destination: Rammohan NaiduThe Hindu